Defence Research and Development Canada

Liberty Defense Receives Contract Award from TSA for Open Architecture Application and Continued Development of AIT Screening Kits up to $3.8M

Retrieved on: 
Wednesday, November 1, 2023

The TSA, an agency of the U.S. Department of Homeland Security, is responsible for all security screening conducted at airports in the United States.

Key Points: 
  • The TSA, an agency of the U.S. Department of Homeland Security, is responsible for all security screening conducted at airports in the United States.
  • TSA's On-Person Screening program aims to detect a growing range of threats, with fewer false alarms and less physical contact.
  • Liberty previously licensed millimeter wave-based, High-Definition Advanced Imaging Technology (HD-AIT) body scanner and shoe screener technologies in March of 2021.
  • For updates and news, please visit the Company website to subscribe to email alerts or follow Liberty Defense on social channels.

Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development

Retrieved on: 
Wednesday, October 11, 2023

TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an update on the development of a next generation lyophilized formulation of Bucillamine.

Key Points: 
  • TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an update on the development of a next generation lyophilized formulation of Bucillamine.
  • Under an agreement with the University of Waterloo, formulation development is ongoing and aims to be completed by the end of December 2023.
  • The Company expects to have its novel lyophilized formulation of Bucillamine ready for clinical evaluation in 2024.
  • The Company intends to explore the novel Bucillamine formulation as a potential treatment for public health medical emergencies including, pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks.

Immervision Awarded $5.7 Million Contract from DRDC to Develop Panoramic Imaging Systems

Retrieved on: 
Tuesday, September 5, 2023

Immervision , the world’s leading developer of advanced vision systems combining optics, image processing, and sensor fusion technology, is pleased to announce the award of a $5.7 million contract from Defence Research and Development Canada (DRDC) for the design and development of panoramic imaging components and systems.

Key Points: 
  • Immervision , the world’s leading developer of advanced vision systems combining optics, image processing, and sensor fusion technology, is pleased to announce the award of a $5.7 million contract from Defence Research and Development Canada (DRDC) for the design and development of panoramic imaging components and systems.
  • This contract underscores Immervision’s industry leading expertise and commitment to creating solutions to see beyond human vision that offer an extended field of view in all environments, vital for situational awareness and operational effectiveness.
  • “Our technology offers wide-angle vision systems featuring Smart Pixel Management, which holds significant potential across diverse applications,” explains Alessandro Gasparini, Executive Vice President and Chief Commercial Officer of Immervision.
  • The unparalleled quality provided by Immervisions panoramic imaging technology, components and systems have had a profound impact globally in products innovation and the development of new solutions for complex imaging challenges.

Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development

Retrieved on: 
Tuesday, August 22, 2023

In addition, the Company may explore the use of the novel Bucillamine formulation as a potent antioxidant and anti-inflammatory treatment for orphan indications in rare inflammatory disorders such as ischemia-reperfusion injury resulting from solid organ transplantation.

Key Points: 
  • In addition, the Company may explore the use of the novel Bucillamine formulation as a potent antioxidant and anti-inflammatory treatment for orphan indications in rare inflammatory disorders such as ischemia-reperfusion injury resulting from solid organ transplantation.
  • The Company has entered into a sponsored research agreement with the University of Waterloo to develop a novel lyophilized Bucillamine injectable formulation for public health medical emergencies and rare inflammatory disorders.
  • Upon completion of the formulation development, which is expected by end-2023, the Company will seek to initiate research studies in line with the Company’s commitment to advancing the clinical and commercial development of Bucillamine through the following strategic initiatives:
    Target Indications: Novel Bucillamine in an injectable version to expand on its potential therapeutic utility targeting rare disorders such as ischemia-reperfusion injury (i.e.
  • At this time, the Company will only provide regular updates via press releases as information becomes available.

Global Anti-Drone Market Size Valuation Envisaged to Reach Over USD 10,395.59 Million By 2032, at 26.6% CAGR Rise: Polaris Market Research

Retrieved on: 
Monday, July 3, 2023

The increasing usage of these systems is associated with creating possible hazards of hacking by terrorists and anti-social groups, which is expected to enhance the anti-drone market demand.

Key Points: 
  • The increasing usage of these systems is associated with creating possible hazards of hacking by terrorists and anti-social groups, which is expected to enhance the anti-drone market demand.
  • Prohibiting illicit activities: Moreover, unmanned aerial vehicles are increasingly used for prohibited and hidden operations like drug trafficking and spying.
  • The growing number of terrorist groups demonstrating the ability to control a variety of drones, including armed ones, has fueled market growth.
  • In addition, detection and disruption systems are used in military, defense applications as well as homeland security sectors.

SynSaber Announces Former Cylance Executive Travis Ryan as Senior VP of Engineering

Retrieved on: 
Tuesday, December 13, 2022

CHANDLER, Ariz., Dec. 13, 2022 /PRNewswire/ -- SynSaber, an early-stage ICS/OT cybersecurity and asset monitoring company, today announced the hiring of Travis Ryan as Senior Vice President of Engineering. Ryan is a United States Marine Corps (USMC) veteran and brings extensive leadership experience in software engineering for globally recognized organizations, including Cylance and General Motors.

Key Points: 
  • CHANDLER, Ariz., Dec. 13, 2022 /PRNewswire/ -- SynSaber , an early-stage ICS/OT cybersecurity and asset monitoring company, today announced the hiring of Travis Ryan as Senior Vice President of Engineering.
  • Ryan is a United States Marine Corps (USMC) veteran and brings extensive leadership experience in software engineering for globally recognized organizations, including Cylance and General Motors.
  • Travis Ryan comes to SynSaber from Forta, where he was the Research and Development Vice President.
  • Before that, he was the Vice President of Engineering at Cylance, overseeing cloud engineering for the first-of-its-kind antivirus product that protected endpoints using machine learning.

Aerospace Materials Market Size Hit USD 69.37 billion by 2029, High demand for aircrafts from emerging economies and low-cost carriers is driving the market growth, Exclusive Report by Exactitude Consultancy

Retrieved on: 
Wednesday, September 21, 2022

PUNE, India, Sept. 21, 2022 /PRNewswire/ -- The global resin aerospace materials market trends are expected to gain momentum by reaching USD 69.37 billion by 2029, while exhibiting a CAGR of 8.1% between 2022 and 2029, Exactitude Consultancy mentions that the market stood at USD 34.41 billion in 2021.

Key Points: 
  • The global aerospace materials market is expected to increase at a significant pace due to increasing demand for properties such as high fuel efficiency and high temperature resistance.
  • Moreover, the global aerospace materials market is anticipated to increase due to the implementation of stringent regulations over carbon emissions across the globe.
  • Composite materials-based aerospace materials accounted for the largest share, in terms of value, of the overall aerospace materials market
    In terms of value, the composite materials-based aerospace materials segment accounted for the largest share of 72.3% of the overall aerospace materials market in 2020.
  • Aircraft manufacturers use a high percentage of composite materials in the new generation aircrafts instead of metals and its alloys used previously.

Chain of Trust Pilot Completed, using Digital Travel Credentials to facilitate a seamless travel experience

Retrieved on: 
Tuesday, September 6, 2022

Entrust has announced the successful conclusion of their participation in the Chain of Trust (CoT) Pilot, a six-month pilot project led by the Canada Border Services Agency (CBSA).

Key Points: 
  • Entrust has announced the successful conclusion of their participation in the Chain of Trust (CoT) Pilot, a six-month pilot project led by the Canada Border Services Agency (CBSA).
  • Launched amid pandemic-restricted travel in March 2021, the CoT Pilot was one of the worlds first use of the latest electronic passport technical standards.
  • Entrust is pleased to have had the opportunity to collaborate with the Government of Canada and all the partners in the Chain of Trust project.
  • The project has proven its value and deepened our understanding of how digital transformation can evolve global travel.

Center for Identification Technology Research Celebrates 20th Year

Retrieved on: 
Thursday, June 30, 2022

Potsdam, NY, June 30, 2022 (GLOBE NEWSWIRE) -- The Center for Identification Technology Research (CITeR), based at Clarkson University, is celebrating its 20th year.

Key Points: 
  • Potsdam, NY, June 30, 2022 (GLOBE NEWSWIRE) -- The Center for Identification Technology Research (CITeR), based at Clarkson University, is celebrating its 20th year.
  • CITeR, which performs research in the growing areas of identity science and biometric recognition, is a National Science Foundation Industry-University Cooperative Research Center.
  • Since awarding its first research grants in 2002, CITeR has performed cutting-edge research as new problems evolve each year.
  • The research found that accurate identification by fingerprint in adults remained high over a 12- 15 -year period.

Patriot One Technologies Delivers Innovative Solution for Protecting First Responders and Firefighters Using Advanced AI Platform

Retrieved on: 
Monday, June 6, 2022

This partnership is part of Canadas Head Up Hands Free program, which is aimed at helping firefighters work safer within dangerous environments.

Key Points: 
  • This partnership is part of Canadas Head Up Hands Free program, which is aimed at helping firefighters work safer within dangerous environments.
  • This specific application of our AI platform will aid firefighters every time they venture into physically dangerous building locations to fight fires and to save trapped occupants.
  • Innovation Solutions Canada tasked us to help address this situation using insights from sensors, correlated data, computer vision and our AI platform to solve this problem.
  • Patriot One, through development by Xtract AI, its AI innovation and development arm, will provide a range of hardware and software technology solutions to achieve the goal of making firefighters jobs safer.